SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,586,199 | -11.9% | 19,540,000 | -13.2% | 0.22% | -7.3% |
Q4 2022 | $22,231,588 | -9.3% | 22,513,000 | -10.5% | 0.23% | -13.0% |
Q3 2022 | $24,514,000 | +2.8% | 25,143,000 | +2.8% | 0.27% | -2.9% |
Q2 2022 | $23,851,000 | +21.6% | 24,447,000 | +22.8% | 0.28% | +35.1% |
Q1 2022 | $19,614,000 | -0.5% | 19,901,000 | 0.0% | 0.20% | -5.1% |
Q4 2021 | $19,714,000 | -10.7% | 19,901,000 | -10.9% | 0.22% | -29.9% |
Q3 2021 | $22,068,000 | -0.7% | 22,348,000 | -0.6% | 0.31% | +3.4% |
Q2 2021 | $22,220,000 | +0.6% | 22,488,000 | -1.4% | 0.30% | -3.2% |
Q1 2021 | $22,095,000 | +38.5% | 22,802,000 | +36.2% | 0.31% | +12.0% |
Q4 2020 | $15,957,000 | +107.0% | 16,738,000 | +101.1% | 0.28% | +63.7% |
Q3 2020 | $7,708,000 | -47.3% | 8,324,000 | -49.6% | 0.17% | -48.1% |
Q2 2020 | $14,613,000 | – | 16,511,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |